Emami Limited
Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $2.1M Total Trade · DGFT Verified
Emami Limited is an Indian pharmaceutical exporter with a total trade value of $2.1M across 4 products in 1 therapeutic categories. Based on 255 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Herbal ($1.2M), Ayurvedic ($731.1K), Churna ($135.5K).
Emami Limited — Export Portfolio & Destination Treemap
Who is Emami Limited? — Company Overview & Market Position
Emami Limited, established in 1974 by Radhe Shyam Agarwal and Radhe Shyam Goenka, is a prominent Indian multinational company specializing in personal care and healthcare products. Headquartered in Kolkata, West Bengal, the company operates under the Corporate Identification Number (CIN) L24246WB1995PLC073513. As of March 2026, Emami Limited employs approximately 3,217 individuals. The company's diverse portfolio includes over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations. In the fiscal year ending March 2025, Emami Limited reported a turnover of ₹3,809 crore, reflecting its robust market presence. The company's official website is www.emamiltd.in.
What Does Emami Limited Export? — Product Portfolio Analysis
Top Products by Export Value
Emami Limited Therapeutic Categories — 1 Specializations
Emami Limited operates across 1 therapeutic categories, with Ayurvedic & Herbal Products (100.0%), representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.
Ayurvedic & Herbal Products
4 products · 100.0% · $2.1M
Product Portfolio — Top 4 by Export Value
Emami Limited exports 4 pharmaceutical products across 1 therapeutic categories.
| # | Product | Category | Export Value | Shipments | Market Share | Rank |
|---|---|---|---|---|---|---|
| 1 | Herbal | Ayurvedic & Herbal Products | $1.2M | 78 | 6.4% | 2 |
| 2 | Ayurvedic | Ayurvedic & Herbal Products | $731.1K | 152 | 3.2% | 7 |
| 3 | Churna | Ayurvedic & Herbal Products | $135.5K | 19 | 7.6% | 4 |
| 4 | Gutika | Ayurvedic & Herbal Products | $21.4K | 6 | 17.1% | 2 |
Emami Limited exports 4 pharmaceutical products across 1 therapeutic categories with a total export value of $2.1M. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.
Key Metrics
Top Categories
Top Export Routes
Related Analysis
Emami Limited — Corporate Profile & Information
Headquarters, ownership, manufacturing facilities, and key leadership
1Corporate Overview
Emami Limited, established in 1974 by Radhe Shyam Agarwal and Radhe Shyam Goenka, is a prominent Indian multinational company specializing in personal care and healthcare products. Headquartered in Kolkata, West Bengal, the company operates under the Corporate Identification Number (CIN) L24246WB1995PLC073513. As of March 2026, Emami Limited employs approximately 3,217 individuals. The company's diverse portfolio includes over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations. In the fiscal year ending March 2025, Emami Limited reported a turnover of ₹3,809 crore, reflecting its robust market presence. The company's official website is www.emamiltd.in.
2Manufacturing Facilities
Emami Limited operates multiple manufacturing facilities across India, including units in Amingaon, Patnagar, Dongri, and Pacharia. These facilities are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP). Additionally, the Amingaon, Patnagar, Dongri, and Pacharia units hold ISO 14001 and ISO 18000 certifications, indicating adherence to environmental and occupational health and safety standards. The company also has an overseas manufacturing unit in Bangladesh, expanding its production capabilities and regional reach.
3Key Leadership
As of March 2026, Emami Limited's leadership includes:
- Harsha V Agarwal: Vice Chairman and Managing Director
- R.S. Goenka: Chairman
- Mohan Goenka: Vice Chairman
- N.H. Bhansali: Chief Financial Officer and Chief Executive Officer - Finance, Strategy, and Business Development
- Gul Raj Bhatia: President - Health Care Division
These executives play pivotal roles in steering the company's strategic direction and operations.
Where Does Emami Limited Export? — Destination Intelligence
Regulated market presence, emerging market penetration, and geographic strategy
1Regulated Markets
Emami Limited's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly detailed in the available sources. The company's international footprint spans over 70 countries, including regions like SAARC, MENAP, Southeast Asia, Africa, Eastern Europe, and the CIS nations. However, specific regulatory approvals or market access statuses in the aforementioned countries are not provided in the available information.
2Emerging Markets
Emami Limited has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's products are available in over 70 countries, including regions such as SAARC, MENAP, Southeast Asia, Africa, Eastern Europe, and the CIS nations. While the company has a significant presence in these regions, specific details regarding WHO prequalification or other certifications enabling access to these markets are not provided in the available sources.
3Geographic Strategy
Emami Limited's geographic strategy demonstrates a diversified approach, with products available in over 70 countries, including regions such as SAARC, MENAP, Southeast Asia, Africa, Eastern Europe, and the CIS nations. This extensive international presence indicates a strategic focus on mitigating concentration risk by tapping into diverse markets. The company's emphasis on Ayurvedic formulations aligns with global health and wellness trends, positioning it favorably in various international markets.
Emami Limited — Manufacturing & Regulatory Profile
FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record
1FDA Status
Specific details regarding Emami Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history are not available in the provided sources. The company's international operations include a manufacturing unit in Bangladesh, expanding its production capabilities and regional reach. However, explicit information about FDA approvals or compliance is not detailed in the available data.
2WHO & EU GMP
Emami Limited's manufacturing units are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP). Additionally, the Amingaon, Patnagar, Dongri, and Pacharia units hold ISO 14001 and ISO 18000 certifications, indicating adherence to environmental and occupational health and safety standards. However, specific details regarding WHO prequalification or EU GMP certificates are not provided in the available sources.
3CDSCO & Indian Regulatory
Emami Limited's manufacturing units in India are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP). The Amingaon, Patnagar, Dongri, and Pacharia units also hold ISO 14001 and ISO 18000 certifications, indicating adherence to environmental and occupational health and safety standards. Specific details regarding approvals from the Central Drugs Standard Control Organisation (CDSCO) or state drug controllers are not explicitly mentioned in the available sources.
4Recent Regulatory Actions
Specific details regarding recent regulatory actions such as Form 483 observations, warning letters, or import alerts are not available in the provided sources. The company's manufacturing units are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP), with additional ISO certifications indicating adherence to environmental and occupational health and safety standards. However, explicit information about recent regulatory actions is not detailed in the available data.
Emami Limited — Competitive Positioning Among Indian Pharma Exporters
Market share comparison, key differentiators, and strategic analysis
1Competitive Landscape
Emami Limited operates in the personal care and healthcare sectors, competing with other FMCG companies such as Hindustan Unilever Limited, Dabur India Limited, and ITC Limited. While specific market share comparisons are not provided in the available sources, Emami's diverse portfolio of over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations, positions it uniquely in the market. The company's emphasis on natural and Ayurvedic formulations aligns with global health and wellness trends, providing a competitive edge in various international markets.
2Key Differentiators
Emami Limited's key differentiators include its extensive portfolio of over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations. The company's manufacturing units are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP), with additional ISO certifications indicating adherence to environmental and occupational health and safety standards. These factors contribute to Emami's strong market presence and consumer trust.
3Strategic Position
Emami Limited's strategic direction focuses on personal care and healthcare products, with a significant emphasis on Ayurvedic formulations. The company's diverse portfolio includes over 550 products across more than 20 brands, catering to various consumer needs. While specific details regarding future outlooks such as ventures into generics, specialty drugs, biosimilars, or Contract Development and Manufacturing Organizations (CDMO) are not provided in the available sources, the company's emphasis on natural and Ayurvedic formulations aligns with global health and wellness trends, positioning it favorably in various international markets.
Buyer Due Diligence Brief — Evaluating Emami Limited as a Supplier
Track record assessment, certifications to verify, and pre-order checks
1Supplier Assessment
Emami Limited's track record as a supplier is supported by its extensive portfolio of over 550 products across more than 20 brands, with a significant focus on Ayurvedic formulations. The company's manufacturing units are ISO 9001:2000 certified and comply with Good Manufacturing Practices (GMP), with additional ISO certifications indicating adherence to environmental and occupational health and safety standards. These factors contribute to the company's reliability and consistency in delivering quality products.
2Certifications to Verify
Importers should verify the following certifications when considering Emami Limited as a supplier:
- ISO 9001:2000 Certification: Indicates adherence to quality management standards.
- Good Manufacturing Practices (GMP) Compliance: Ensures manufacturing processes meet industry standards.
- ISO 14001 Certification: Demonstrates commitment to environmental management.
- ISO 18000 Certification: Reflects compliance with occupational health and safety standards.
These certifications can typically be verified through official ISO certification bodies or directly from the company's official communications.
3Due Diligence Checklist
When conducting due diligence on Emami Limited, consider the following steps:
Frequently Asked Questions — Emami Limited
How many pharmaceutical products does Emami Limited export from India?
Emami Limited exports 4 pharmaceutical products across 1 therapeutic categories. The top exports are Herbal ($1.2M), Ayurvedic ($731.1K), Churna ($135.5K), Gutika ($21.4K). Total export value is $2.1M.
What is Emami Limited's total pharmaceutical export value?
Emami Limited's total pharmaceutical export value is $2.1M, based on 255 verified shipments recorded in Indian Customs (DGFT) data.
What therapeutic categories does Emami Limited cover?
Emami Limited exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 4 products).
Get Full Emami Limited Export Intelligence
Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Official References & Regulatory Resources
Verify manufacturer licensing, GMP certification, and export registration with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Matching: Emami Limited identified across shipments using name normalization.
- 2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 3.Market Share: Calculated per product as Emami Limited's capped value divided by total Indian exports for that product.
- 4.Shipment Count: Based on 255 individual customs records matching Emami Limited.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Products Tracked
1 therapeutic categories
Expert-Reviewed
By pharmaceutical trade specialists
Data Source & Methodology
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.